Eli Lilly's head of obesity talks weight-loss innovations for 2025 — from an Ozempic-like pill to a triple-threat shot
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risks
The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...
GLP-1 drugs like Ozempic may have health benefits, but they come with risks
With with GLP-1 drugs, gastrointestinal issues, such as nausea, vomiting, constipation, and gastroesophageal reflux disease, ...
CNET2d
Microcurrent Devices: Effectiveness, Tips for Use and Are They Worth the Money? We Asked Skin Experts
If you have a microcurrent device on your wishlist, here are some benefits and drawbacks to consider before you buy one.
Scientific American2d
What’s in ZYN, the FDA-Authorized Nicotine Pouch? Is It Harmful?
ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some questions linger. Experts explain the efficacy and potential health risks of nicot ...
Novo Nordisk next-gen shot shows 22% weight loss in early results
One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...
FDA bans Red 3 dye from food and drugs. A scientist explains the artificial color's health risks and long history
Red 3—also called FD&C Red No. 3, erythrosine or E127—has been widely used in food, cosmetics and pharmaceuticals since its FDA approval in 1969. You've likely encountered Red 3 before. It's a common ...
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...